Ardent Health (NYSE:ARDT – Get Free Report) and IceCure Medical (NASDAQ:ICCM – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, analyst recommendations, earnings, institutional ownership and profitability.
Insider and Institutional Ownership
0.6% of IceCure Medical shares are held by institutional investors. 1.7% of Ardent Health shares are held by insiders. Comparatively, 2.4% of IceCure Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Risk and Volatility
Ardent Health has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500. Comparatively, IceCure Medical has a beta of 0.52, suggesting that its stock price is 48% less volatile than the S&P 500.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Ardent Health | 2 | 5 | 7 | 0 | 2.36 |
| IceCure Medical | 1 | 1 | 1 | 0 | 2.00 |
Ardent Health presently has a consensus price target of $14.25, suggesting a potential upside of 40.05%. IceCure Medical has a consensus price target of $2.64, suggesting a potential upside of 627.70%. Given IceCure Medical’s higher possible upside, analysts plainly believe IceCure Medical is more favorable than Ardent Health.
Profitability
This table compares Ardent Health and IceCure Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Ardent Health | 2.15% | 14.30% | 4.58% |
| IceCure Medical | -445.61% | -221.04% | -118.89% |
Valuation & Earnings
This table compares Ardent Health and IceCure Medical”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Ardent Health | $6.32 billion | 0.23 | $135.81 million | $0.96 | 10.60 |
| IceCure Medical | $3.38 million | 8.70 | -$15.06 million | ($0.24) | -1.51 |
Ardent Health has higher revenue and earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks.
Summary
Ardent Health beats IceCure Medical on 10 of the 14 factors compared between the two stocks.
About Ardent Health
Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
About IceCure Medical
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
